The anticipated encore volume of the Biomedical Research Reports Series, Hepatitis C is the first book that
offers comprehensive and up-to-date coverage of this "silent epidemic." The subject matter ranges from
basic science to clinical medicine, with contributions from more than 30 international experts in the field. This
important new book details the hepatitis C virus and the disease that it causes, including its prevalence, means
of spread, symptoms, complications, natural history, prevention, and therapy.
The editors, T. Jake Liang, M.D., and Jay H. Hoofnagle, M.D., are both hepatologists and clinical and laboratory
researchers who are well known leaders in the hepatitis field. Their team of authors provide the latest information
on key issues such as the role of hepatitis C in liver cancer and evolving therapy for hepatitis C, including special
subgroups of patients such as children, patients with renal failure, patients undergoing liver transplantation,
and patients with HIV coinfection. The book also addresses future directions in antiviral therapy of hepatitis
C and the real challenges of developing a vaccine. Hepatitis C is the integrated reference book for all researchers,
clinicians, and students dealing with this troubling virus.
Key Features
Provides comprehensive coverage of hepatitis C, ranging from basic science to clinical application
Includes contributions from more than 30 international experts in the field
Supplies current recommendations on management of hepatitis C
Designed in an easy-to-use format with consistent organization
